Sofgen Pharmaceuticals is an integrated contract development and manufacturing organisation (CDMO) supplying end-to-end softgel solutions for pharma and healthcare companies. Our solutions are designed for product launches in North America and other tightly regulated markets.
To help us offer positive experiences at each customer touchpoint, we mix our deep softgel knowledge and expertise with flexibility and a desire to develop customised products that exceed customers’ expectation. We build relationships based on connectivity, trust and empathy with our clients.
Our Center for Pharmaceutical Excellence in West Palm Beach, Florida, allows us to deliver pharmaceutical products to our strategic partners and enable the continued quality of their brands, which are their most valued asset.
By offering innovative technologies for oral delivery systems, as well as substantial knowledge of Softgel technologies, we can provide the highest degree of flexibility and on-time deliveries with the best possible yields and quality.
Our goal is to provide an unparalleled experience with reliable development manufacturing services, niche proprietary products and innovation in technologies, for the health and wellbeing of consumers and patients in key markets.
Research into advanced delivery technologies
Sofgen Pharmaceuticals offers novel technologies and advanced softgel solutions for RX, OTC, and specialised nutraceuticals. These include:
Other technologies we provide include:
Full-service formulation research and development services
At Sofgen Pharmaceuticals, we work with the efficiency, quality and flexibility to develop and materialise your ideas. Our team has extensive knowledge of development services and are driven by science and technology, allowing us to solve any formulation challenges along the way.
Among the R&D services we offer are:
Support and value at all stages of product development
Softigel’s team works closely with our customers to understand expectations and develop a regulatory strategy that guarantees the best quality, timely submissions, and faster, positive registration outcomes.
We also count with experience preparing submissions in eCTD format and provide support in the application phase and beyond, including annual reports and other post approval submissions.
We have proven expertise in technology transfers, product launches, product development, and manufacturing technologies.
We are Procaps Group
Procaps is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have a direct presence in 13 countries in the Americas and more than 4,900 collaborators working under a sustainable model.
Procaps develops, manufactures, and markets over the counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions
Procaps Group today is the largest pharmaceutical CDMO in Latin America and in the top three worldwide in terms of volume of softgel production capacity.